Prediction of long-term humoral response induced by the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola

Prediction of long-term humoral response induced by the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola

Abstract The persistence of the long-term immune response induced by the heterologous Ad26.ZEBOV, MVA-BN-Filo two-dose vaccination regimen against Ebola has been investigated in several clinical trials. Longitudinal data on IgG-binding antibody concentrations were analyzed from 487 participants enro...

Full description

Bibliographic Details
Main Authors: Marie Alexandre, Mélanie Prague, Chelsea McLean, Viki Bockstal, Macaya Douoguih, Rodolphe Thiébaut, for the EBOVAC 1 and EBOVAC 2 Consortia
Format: Article
Language:English
Published: Nature Portfolio 2023-11-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-023-00767-y

Internet

https://doi.org/10.1038/s41541-023-00767-y

Similar Items